Big Pharma Oncology Strategies Aim To Treat Cancer Earlier

Combinations May Advance Novel Drugs Faster

 
• By Mandy Jackson

ADCs, radiopharmaceuticals, precision medicines and T-cell engagers dominated R&D pipelines reviewed by 12 big pharmas at the first annual AACR Oncology Industry Partnering Event.

A 3D illustration depicting Cancer Cells in the crosshairs, related to cancer treatment
Pharma firms are pursuing new ways of addressing known targets • Source: Shutterstock

More from Anticancer

More from Therapy Areas